Suppr超能文献

在英国,选择腹腔镜切除术在结直肠癌手术中具有生存获益。

Selection for laparoscopic resection confers a survival benefit in colorectal cancer surgery in England.

作者信息

Askari Alan, Nachiappan Subramanian, Currie Andrew, Bottle Alex, Athanasiou Thanos, Faiz Omar

机构信息

Surgical Epidemiology, Trials and Outcome Centre (SETOC), St Mark's Hospital, Imperial College London, Harrow, Middlesex, HA1 3UJ, UK.

Faculty of Medicine, School of Public Health, Dr Foster Unit, Imperial College London, London, UK.

出版信息

Surg Endosc. 2016 Sep;30(9):3839-47. doi: 10.1007/s00464-015-4686-8. Epub 2016 Apr 8.

Abstract

INTRODUCTION

Laparoscopic surgery is being increasingly used in colorectal cancer resections. The aim of this national study was to determine whether laparoscopy confers a long-term survival advantage in colorectal cancer.

METHODS

A national administrative data set (Hospital Episode Statistics-HES) encompassing all elective hospital admissions in England between 2001 and 2011 was analysed. All patients that had a colorectal cancer resection (open or laparoscopic) were identified. Cox hazard regression was used to determine differences in overall survival (10 year) between the open and laparoscopy groups.

RESULTS

A total of 141,682 patients underwent elective surgery for colorectal cancer, of which 20.9 % (n = 29,550) had a laparoscopic procedure. The median 5-year survival in the open group was 36.1 months compared with 46.1 months in the laparoscopic group (p = <0.001). Survival analysis demonstrated laparoscopy to be an independent predictor of survival. Patients who underwent laparoscopic resection were 18 % less likely to die than patients who had an open CRC resection (HR 0.82, CI 0.79-0.83, p < 0.001). This survival benefit persisted even when initial post-operative mortality (90 day) was excluded (HR 0.87, CI 0.85-0.90, p < 0.001). Subgroup analysis, exploring the effect of CRC laparoscopic surgery on survival in the elderly (>79 years old), demonstrated similar survival benefit amongst patients treated using laparoscopy (HR 0.90, CI 0.86-0.94, p < 0.001). Patients not undergoing adjuvant chemotherapy were more likely to survive if they underwent laparoscopic resection (HR 0.81, CI 0.78-0.83, p < 0.001). Similarly, patients undergoing adjuvant chemotherapy demonstrated a survival benefit if a minimal access surgical approach was utilised (HR 0.86, CI 0.81-0.91, p < 0.001).

CONCLUSION

Laparoscopy confers a survival benefit, irrespective of age and administration of adjuvant chemotherapy, beyond the initial post-operative period in patients selected for elective colorectal cancer resection.

摘要

引言

腹腔镜手术在结直肠癌切除术中的应用越来越广泛。这项全国性研究的目的是确定腹腔镜手术是否能为结直肠癌患者带来长期生存优势。

方法

分析了一个涵盖2001年至2011年英格兰所有择期住院患者的全国性行政数据集(医院事件统计-HES)。确定了所有接受结直肠癌切除术(开放或腹腔镜)的患者。采用Cox风险回归分析来确定开放手术组和腹腔镜手术组之间的总生存率(10年)差异。

结果

共有141,682例患者接受了择期结直肠癌手术,其中20.9%(n = 29,550)接受了腹腔镜手术。开放手术组的5年中位生存期为36.1个月,而腹腔镜手术组为46.1个月(p = <0.001)。生存分析表明腹腔镜手术是生存的独立预测因素。接受腹腔镜切除术的患者死亡可能性比接受开放性结直肠癌切除术的患者低18%(风险比0.82,可信区间0.79 - 0.83,p < 0.001)。即使排除术后初期死亡率(90天),这种生存获益仍然存在(风险比0.87,可信区间0.85 - 0.90,p < 0.001)。亚组分析探讨了结直肠癌腹腔镜手术对老年患者(>79岁)生存的影响,结果显示接受腹腔镜手术治疗的患者也有类似的生存获益(风险比0.90,可信区间0.86 - 0.94,p < 0.001)。未接受辅助化疗的患者若接受腹腔镜切除术更有可能存活(风险比0.81,可信区间0.78 - 0.83,p < 0.001)。同样,接受辅助化疗的患者若采用微创手术方法也显示出生存获益(风险比0.86,可信区间0.81 - 0.91,p < 0.001)。

结论

对于选择进行择期结直肠癌切除术的患者,腹腔镜手术在术后初期之后能带来生存获益,且与年龄和辅助化疗的使用无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验